Xilio Therapeutics, Inc.
XLO
Revenue
8.08M
▲5.15M▲175.90%
3 Months ChangeAssets
133.81M
▲30.10M▲29.02%
3 Months ChangeLiabilities
126.74M
▲33.73M▲36.26%
3 Months ChangeFree Cash Flow
28.96M
▲54.38M▲213.91%
24 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-13
Form 8-K
ID: 0001558370-24-012775
2024-08-08
Form 10-Q
ID: 0001558370-24-011471
2024-08-08
Form 8-K
ID: 0001558370-24-011470
2024-06-17
Form 8-K
ID: 0001558370-24-009247
2024-06-13
Form 8-K
ID: 0001558370-24-009138
2024-05-14
Form 10-Q
ID: 0001558370-24-008068
2024-05-14
Form 8-K
ID: 0001558370-24-008063
2024-04-01
Form 8-K
ID: 0001558370-24-004528
2024-03-28
Form 8-K
ID: 0001558370-24-004249
2024-03-28
Form 8-K
ID: 0001558370-24-004165